Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.
Ali SS, Demetriou C, Parodis I, Tan AL, Edgar Gracia-Ramos A, Joshi M, Caballero-Uribe CV, Saha S, Lilleker JB, Nune A, Pauling JD, Wincup C, Jagtap K, Dey D, Milchert M, Distler O, Chinoy H, Agarwal V, Gupta L, Nikiphorou E; COVAD Study Group. Ali SS, et al. Rheumatol Adv Pract. 2024 Dec 30;9(1):rkae154. doi: 10.1093/rap/rkae154. eCollection 2025. Rheumatol Adv Pract. 2024. PMID: 39846050 Free PMC article.
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study.
Shaharir SS, Nawi AM, Mariamutu TN, Kamaruzaman L, Said MSM, Rajalingham S, Parodis I, Sarkar M, Shinjo SK, Kadam E, Ziade N, Tan CL, Gullemin F, Caballero-Uribe CV, Tan AL, Andreoli L, Parihar J, Yaadav P, Saha S; COVAD Study Group; Gupta L, Agarwal V. Shaharir SS, et al. Int J Rheum Dis. 2025 Jan;28(1):e70043. doi: 10.1111/1756-185X.70043. Int J Rheum Dis. 2025. PMID: 39791506
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.
Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, Wallace ZS, Walters G, Muso E, Tesar V, Pusey CD, Little MA, Merkel PA, Walsh M, Jayne DRW, Kronbichler A; PEXIVAS Investigators. Odler B, et al. Kidney Int. 2024 Dec 19:S0085-2538(24)00911-6. doi: 10.1016/j.kint.2024.11.029. Online ahead of print. Kidney Int. 2024. PMID: 39708998 Free article.
NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort.
Hamroun S, Couderc M, Flipo RM, Sellam J, Richez C, Dernis E, Frazier A, Gossec L, Gervais E, Marotte H, Dunogeant L, Lukas C, Deroux A, Guettrot-Imbert G, Le Guern V, Costedoat-Chalumeau N, Molto A; GR2 study group. Hamroun S, et al. RMD Open. 2024 Nov 29;10(4):e004745. doi: 10.1136/rmdopen-2024-004745. RMD Open. 2024. PMID: 39615886 Free PMC article.
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19.
Rodrigues PB, de Rezende Rodovalho V, Sencio V, Benech N, Creskey M, Silva Angulo F, Delval L, Robil C, Gosset P, Machelart A, Haas J, Descat A, Goosens JF, Beury D, Maurier F, Hot D, Wolowczuk I, Sokol H, Zhang X, Ramirez Vinolo MA, Trottein F. Rodrigues PB, et al. Among authors: maurier f. bioRxiv [Preprint]. 2024 Nov 6:2024.11.05.622058. doi: 10.1101/2024.11.05.622058. bioRxiv. 2024. PMID: 39574606 Free PMC article. Preprint.
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
Dey M, Doskaliuk B, Parodis I, Lindblom J, Wincup C, Joshi M, Dey D, Katchamart W, Kadam E, Sen P, Shinjo SK, Nune A, Goo PA, Ziade N, Chen YM, Traboco LS, Gutiérrez CET, Vaidya B, Agarwal V, Gupta L, Nikiphorou E; COVAD Study Group. Dey M, et al. Rheumatol Int. 2024 Dec;44(12):2853-2861. doi: 10.1007/s00296-024-05742-x. Epub 2024 Nov 6. Rheumatol Int. 2024. PMID: 39503760 Free PMC article.
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
Palazzo L, Lindblom J, Kihlgren Olsson E, Nikiphorou E, Wincup C, Saha S, Shaharir SS, Katchamart W, Akarawatcharangura Goo P, Traboco L, Chen YM, Lilleker JB, Nune A, Pauling JD, Agarwal V, Dzifa D, Toro Gutiérrez CE, Caballero-Uribe CV, Chinoy H; COVAD Study Group; Agarwal V, Gupta L, Parodis I. Palazzo L, et al. Rheumatol Int. 2024 Oct;44(10):1923-1933. doi: 10.1007/s00296-024-05682-6. Epub 2024 Aug 13. Rheumatol Int. 2024. PMID: 39138675 Free PMC article.
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
Alunno A, Carubbi F, Tan AL, Sen P, Cavagna L, Joshi M, Day J, Saha S, Gutiérrez CET, Caballero-Uribe CV, Distler O, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Alunno A, et al. Rheumatol Int. 2024 Sep;44(9):1725-1731. doi: 10.1007/s00296-024-05654-w. Epub 2024 Jul 13. Rheumatol Int. 2024. PMID: 39003346 Free PMC article.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Kuwana M, Joshi M, Gracia-Ramos AE, Boyd P, Yaadav P, Cheng K, Kobert L, Cavagna L, Sen P, Day J, Makol A, Gutiérrez CET, Caballero-Uribe CV, Saha S, Parodis I, Dey D, Nikiphorou E, Distler O, Kadam E, Tan AL, Shinjo SK, Ziade N, Knitza J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Shumnalieva R, et al. Int J Rheum Dis. 2024 May;27(5):e15178. doi: 10.1111/1756-185X.15178. Int J Rheum Dis. 2024. PMID: 38742751
200 results